These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 25314644)
1. The effect of turmeric (Curcuma longa) extract on the functionality of the solute carrier protein 22 A4 (SLC22A4) and interleukin-10 (IL-10) variants associated with inflammatory bowel disease. McCann MJ; Johnston S; Reilly K; Men X; Burgess EJ; Perry NB; Roy NC Nutrients; 2014 Oct; 6(10):4178-90. PubMed ID: 25314644 [TBL] [Abstract][Full Text] [Related]
2. Curcumin attenuates lipopolysaccharide-induced renal inflammation. Zhong F; Chen H; Han L; Jin Y; Wang W Biol Pharm Bull; 2011; 34(2):226-32. PubMed ID: 21415532 [TBL] [Abstract][Full Text] [Related]
3. Oral administration of powdered dried rhizomes of Curcuma longa L. (turmeric, Zingiberaceae) is effective in the treatment of doxorubicin-induced kidney injury in rats. Russo ER; Facincani I; Nakazato KC; Coimbra TM; Crevelin EJ; Pereira AMS; Carmona F Phytother Res; 2018 Dec; 32(12):2408-2416. PubMed ID: 30109739 [TBL] [Abstract][Full Text] [Related]
4. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Kocaadam B; Şanlier N Crit Rev Food Sci Nutr; 2017 Sep; 57(13):2889-2895. PubMed ID: 26528921 [TBL] [Abstract][Full Text] [Related]
5. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review. Hosseini A; Hosseinzadeh H Biomed Pharmacother; 2018 Mar; 99():411-421. PubMed ID: 29367110 [TBL] [Abstract][Full Text] [Related]
6. A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease. Sardou HS; Vosough PR; Abbaspour M; Akhgari A; Sathyapalan T; Sahebkar A Inflammopharmacology; 2023 Jun; 31(3):1095-1105. PubMed ID: 36757584 [TBL] [Abstract][Full Text] [Related]
7. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Mahady GB; Pendland SL; Yun G; Lu ZZ Anticancer Res; 2002; 22(6C):4179-81. PubMed ID: 12553052 [TBL] [Abstract][Full Text] [Related]
8. Curcumin and Turmeric Modulate the Tumor-Promoting Effects of Iron In Vitro. Messner DJ; Robinson T; Kowdley KV Nutr Cancer; 2017 Apr; 69(3):481-489. PubMed ID: 28129008 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of 12/15 lipoxygenase by curcumin and an extract from Curcuma longa L. Bezáková L; Košťálová D; Obložinský M; Hoffman P; Pekárová M; Kollárová R; Holková I; Mošovská S; Sturdík E Ceska Slov Farm; 2014 Feb; 63(1):26-31. PubMed ID: 24568335 [TBL] [Abstract][Full Text] [Related]
10. Turmeric (Curcuma longa) attenuates food allergy symptoms by regulating type 1/type 2 helper T cells (Th1/Th2) balance in a mouse model of food allergy. Shin HS; See HJ; Jung SY; Choi DW; Kwon DA; Bae MJ; Sung KS; Shon DH J Ethnopharmacol; 2015 Dec; 175():21-9. PubMed ID: 26342520 [TBL] [Abstract][Full Text] [Related]
11. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials. White CM; Pasupuleti V; Roman YM; Li Y; Hernandez AV Pharmacol Res; 2019 Aug; 146():104280. PubMed ID: 31121255 [TBL] [Abstract][Full Text] [Related]
12. An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells. Dimas K; Tsimplouli C; Houchen C; Pantazis P; Sakellaridis N; Tsangaris GT; Anastasiadou E; Ramanujam RP Altern Ther Health Med; 2015; 21 Suppl 2():46-54. PubMed ID: 26308760 [TBL] [Abstract][Full Text] [Related]
13. A transcriptomic analysis of turmeric: Curcumin represses the expression of cholesterol biosynthetic genes and synergizes with simvastatin. Einbond LS; Manservisi F; Wu HA; Balick M; Antonetti V; Vornoli A; Menghetti I; Belpoggi F; Redenti S; Roter A Pharmacol Res; 2018 Jun; 132():176-187. PubMed ID: 29408497 [TBL] [Abstract][Full Text] [Related]
14. Isolation and In silico Study of Curcumin from Curcuma longa and Its Anti-Diabetic Activity. Vaithiyalingam M; Sumathi DL; Sabarathinam S Appl Biochem Biotechnol; 2023 Feb; 195(2):947-957. PubMed ID: 36242725 [TBL] [Abstract][Full Text] [Related]
15. The role of Curcuma longa against doxorubicin (adriamycin)-induced toxicity in rats. Mohamad RH; El-Bastawesy AM; Zekry ZK; Al-Mehdar HA; Al-Said MG; Aly SS; Sharawy SM; El-Merzabani MM J Med Food; 2009 Apr; 12(2):394-402. PubMed ID: 19459743 [TBL] [Abstract][Full Text] [Related]
16. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review. Soleimani V; Sahebkar A; Hosseinzadeh H Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523 [TBL] [Abstract][Full Text] [Related]
17. High performance curcumin subcritical water extraction from turmeric (Curcuma longa L.). Valizadeh Kiamahalleh M; Najafpour-Darzi G; Rahimnejad M; Moghadamnia AA; Valizadeh Kiamahalleh M J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():191-198. PubMed ID: 27107245 [TBL] [Abstract][Full Text] [Related]
18. Antifungal activity of turmeric oil extracted from Curcuma longa (Zingiberaceae). Apisariyakul A; Vanittanakom N; Buddhasukh D J Ethnopharmacol; 1995 Dec; 49(3):163-9. PubMed ID: 8824742 [TBL] [Abstract][Full Text] [Related]
19. Is Curcumin a Possibility to Treat Inflammatory Bowel Diseases? Mazieiro R; Frizon RR; Barbalho SM; Goulart RA J Med Food; 2018 Nov; 21(11):1077-1085. PubMed ID: 29957091 [TBL] [Abstract][Full Text] [Related]
20. Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets. Ghanaatian N; Lashgari NA; Abdolghaffari AH; Rajaee SM; Panahi Y; Barreto GE; Butler AE; Sahebkar A J Cell Physiol; 2019 Aug; 234(8):12237-12248. PubMed ID: 30536381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]